| Literature DB >> 35177986 |
Melvin Adhiambo Ochieng1,2, Widad Ben Bakrim2,3, Gabin Thierry M Bitchagno2, Mona F Mahmoud4, Mansour Sobeh2.
Abstract
Medicinal plants have been used since ancient times for human healthcare as drugs, spices, and food additives. The progress in technology and medicine observed, the last decades, has improved the quality of life and healthcare but with worrisome drawbacks. Side effects caused by synthetic drugs for instance originate sometimes irreversible health disorders. Natural substances, in contrast, are biologically and environmentally friendly. Syzygium jambos L. (Alston) also known as rose apple conveys a long history as essential traditional medicine with a broad spectrum of application in various cultures. The plant discloses a diverse group of secondary metabolites and extracts that displayed major susceptibilities towards various health concerns especially stress-related and inflammatory diseases. Despite a rich literature about the plant, the chemistry and biology of S. jambos have not been comprehensively reviewed yet. Accordingly, we present herein a literature survey of rose apple which aims to draw the chemical identity of the plant and establish a consistent discussion on the respective biological application of plant extracts and their corresponding traditional uses. The present work could provide a scientific basis for future studies and necessary information for further investigations of new drug discovery.Entities:
Keywords: Syzygium jambos; antiinflammatory; antioxidant; medicinal plants; pharmacological activities
Year: 2022 PMID: 35177986 PMCID: PMC8845460 DOI: 10.3389/fphar.2022.786712
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
FIGURE 1Syzygium jambos (A) tree, (B) flowers, (C) unripe fruits and (D) seeds.
Phytoconstituents from S. jambos.
| Class of compounds | Compound names | Plant organs | Characterization methods | References |
|---|---|---|---|---|
| Flavonoids | Quercetin | Fruit, whole plant, leaves | HPLC, ESI-MS, EIMS, IR, 1D and 2D NMR |
|
| Quercitrin | Fruit |
| ||
| Rutin | Whole plant |
| ||
| 5,4′-dihydroxy, 7-methoxy, 6-methyl-flavone | ||||
| Isoetin-7- | ||||
| Myricetin 3- | Leaves |
| ||
| Kaempferol |
| |||
| Quercetin 3- | Whole plant |
| ||
| Quercetin 3- | ||||
| Quercetin 3- | ||||
| Myricetin 3- | ||||
| Myricetin 7-methylether 3- | ||||
| Myricetin 3′,5′-dimethyl ether 3- | ||||
| Myrigalone B | Leaves |
| ||
| Phloretin 4 - | ||||
| Myrigalone G | ||||
| Triterpenoids | Oleanolic acid | Leaves |
| |
| Betulinic acid | ||||
| Friedelin |
| |||
| 3-nor-2,3-Secofriedelan | Stem bark, leaves |
| ||
| Β-Sitosterol | Stem bark |
| ||
| Β-Amyrin acetate |
| |||
| Lupeol | ||||
| Ursolic acid |
| |||
| 3-Acetyl-ursolic acid | ||||
| Asiatic acid | ||||
| Arjunolic acid | ||||
| Morolic acid 3-o-caffeate |
| |||
| Phloroglucinol | Jambone A | Leaves |
| |
| Jambone B | ||||
| Jambone C | ||||
| Jambone D | ||||
| Jambone E | ||||
| Jambone F | ||||
| Jambone G | ||||
| Ellagic acid and ellagitannins | Tellimagrandin | Leaves |
| |
| Limagrandin I | ||||
| Strictinin | ||||
| Casuarictin |
| |||
| 2,3-hexahydroxydiphenoylglucose stachyurin |
| |||
| Casuariin | Stem bark, leaves | |||
| 3,3′,4′-tri- | Leaves |
| ||
| 3,3′,4′-tri- | ||||
| 1- |
| |||
| Castalagin | Stem bark, leaves |
| ||
| Vescalagin | ||||
| Phyllanthusiin G | Stem bark |
| ||
| Ellagic acid pentoside | ||||
| Ellagic acid | ||||
| Methyl ellagic acid sulfate | ||||
| Phenolic acid | Gallic acid | Leaves, fruit | HPLC-PDA-MS/MS and GC-MS |
|
| Cinnamic acid |
| |||
| 3,4,5-Trihydroxybenzoic acid | ||||
| Prenylbenzoic acid 4-β-d-glucoside | ||||
| 4′-hydroxy-3′-methoxyphenol-β-d-[6- | ||||
| Caffeic acid | Leaves |
| ||
| Chlorogenic acid | ||||
| Rosmarinic acid rhamnoside |
| |||
| Organic acids | Citric acid | Leaves | GC-MS | |
| Malic acid | ||||
| Volatile compounds | Phenylacetic acid |
| ||
| Hexanal |
| |||
| Geraniol | ||||
| Citronellol | ||||
| Hotrienol | ||||
| (E)-cinnamyl alcohol | ||||
| Β-phenylethyl alcohol | ||||
| (E)-2-methyl-2-buten-1-ol | ||||
| Linalool | ||||
| (Z)-3-hexen-1-ol | ||||
| 3-phenylpropanol | ||||
| (Z)-3-hexen-1-ol | ||||
| Β-caryoplyllane | ||||
| Α-humulene | ||||
| Β-bisabolene | ||||
| (e,e)-α-farnesene | ||||
| Caryophyllenyl alcohol | ||||
| Caryolan-8-ol | ||||
| N-heneicosane | ||||
| Viridiflorol | ||||
| Ledol | ||||
| Humulene epoxide ii 1 | ||||
| Epi-cedrol 2 | ||||
| Epi-α-muurolol | ||||
| Trans-(ipp vc oh) sesquisabinene hydrate | ||||
| 4,8-α-Epoxy-caryoplyllane | ||||
| Trans-caryophyllene | ||||
| Σ-Cadinene | ||||
| Τ-Muurolol | ||||
| Neophytadiene | ||||
| 2-propen-1-one, 1-(2,6-dihydroxy-4-methoxyphenyl)-3-phenyl-, (e)- | ||||
| 4h-1-Benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-6,8-dimethyl-2-phenyl-, (s)- |
| |||
| 1h-Benzoimidazole, 5-ethoxy-2-phenethylsulfanyl | ||||
| 2,3-Dihydro-2,4-diphenyl-1h-1,5-benzodiazepine | ||||
| α -Tocopherol | ||||
| [3-Deuterium)- α -tocopheryl methyl ether |
| |||
| Fatty acid | Lauric acid | |||
| Caproic acid | ||||
| Hentriacontane | ||||
| 3-Pentadecylphenol (3-n-pentadecylphenol) | ||||
| (e, e)-1,4,4-trimethyl-8-methylene-1,5-cycloundecadiene | ||||
| Methyl (z)-5,11,14,17-eicosatetraenoate | ||||
| 4h-1-benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-phenyl-(S) |
| |||
| 3.7,11,15-tetramethyl-2-hexadecen-1-ol | ||||
| Hexadecanoic acid, methyl ester | ||||
| Hexadecanoic acid | ||||
| Hexadecanoic acid, ethyl ester | ||||
| 9,12-Octadecadienoic acid, methyl ester | ||||
| 9,12,15-Octadecatrienoic acid, methyl ester, (z,z,z)- | ||||
| 9,12-Octadecadienoic acid (z,z)- | ||||
| 8,11,14-Eicosatrienoic acid, (z,z,z)- | ||||
| Ethyl linoleate | ||||
| Octadecanoic acid, ethyl ester | ||||
| Hexadecanoic acid, 2-hydroxy-1-(hydroxymethyl)ethyl ester | ||||
| 2,6,10,14,18,22-Tetracosahexaene, 2,6,10,15,19,23-hexamethyl |
FIGURE 2Selected secondary metabolites from S. jambos.
FIGURE 3Biological activities of S. jambos.
Antimicrobial activity of S. jambos extracts.
| Extract | Tested strains | Key results | Reference |
|---|---|---|---|
| Leaves | |||
| Methanol extract |
| MIC = 797.5 µg/ml |
|
| A. Hydropilia | MIC = 384.6 µg/ml | ||
|
| MIC = 182.6 µg/ml | ||
|
| MIC = 46.5 µg/ml | ||
|
| These bacteria were not susceptible by | ||
| Ethanolic extract | Chromobacterium violaceum DMST 21761 | At 500 µg/ml, a highest inhibition in QS-dependent violacein pigment production was observed up to 90% |
|
|
| |||
| Ethanolic extract |
| At sub-MIC (500 µg/ml), the extract showed significant reduction in QS-regulated virulence determinants |
|
| The extract showed also 31.96% of decreases in biofilm formation of | |||
| Ethanolic extract | P. acnes | MIC = 31.3 µg/ml |
|
| Hydroethanolic extract |
|
|
|
| No activity against | |||
| Decoction | P. vulgaris (ATCC 6896) | MIC = 31 μg/ml and MBC = 1.0 mg/ml |
|
| S. saprophyticus (ATCC 15305) | MIC = 500 μg/ml and MBC = 2.0 mg/ml | ||
|
| MIC = 500 μg/ml and MBC = 1.0 mg/ml | ||
| Aqueous and methanolic extracts | C. albicans (ATCC10231) | IZ = 8–13 mm |
|
| Epidermophyton floccosum (ATCC 26072) | IZ = > 16 mm | ||
| Microsporum gypseum (ATCC7911) | IZ = 12.3 mm | ||
| Trichophyton mentagrophytes BSL2 (ATCC 13996) | IZ > 10 mm | ||
| Trichophyton rubrum (ATCC 22402) | IZ > 10 mm | ||
| Ethanolic extract |
| Φmm = 20 mm |
|
|
| Φmm = 8 mm | ||
| C. albicans | Φmm = 21 mm | ||
| A. niger | Φmm = 7 mm | ||
| Acetone extract |
| MIC = 128 μg/ml |
|
| 85% MeOH |
| Φ = 13.5, 11.0, 13.5, and 11.5 mm, respectively |
|
| Defatted 85% MeOH | Φmm ranging between 10 and 13.5 mm | ||
| Petroleum ether | Φmm ranging between 8.5 and 11.5 mm | ||
| Dichloromethane | Φmm ranging between 9 and 11.5 mm | ||
| Ethyl acetate | Φmm ranging between 11.5 and 13.5 mm | ||
| n-Butanol | Φmm ranging between 9.5 and 14.5 mm | ||
| Aqueous | Φmm ranging between 12.5 and 15.5 mm | ||
| Methanolic extract | 26 strains of | MIC ranging between 32 and 512 μg/ml |
|
|
| MIC = 64 μg/ml | ||
|
| MIC = 512 μg/ml | ||
|
| MIC = 512 μg/ml | ||
| Providencia | MIC = 128 and 256 μg/ml, respectively | ||
|
| MIC = 64 μg/ml | ||
|
| MIC range of 128 and 512 μg/ml | ||
|
| |||
| Acetone extract |
| Φmm ranging between 7 and 12 mm | |
| Aqueous extract |
| Φmm ranging between 12 and 16 mm |
|
|
| Φmm ranging between 6 and 17 mm | ||
|
| Φmm ranging between 12 and 15 mm | ||
|
| Φmm ranging between 9 and 12 mm | ||
|
| Φmm ranging between 12 and 15 mm | ||
|
| Φmm ranging between 8 and 12 mm | ||
|
| Φmm ranging between 12 and 15 mm | ||
|
| |||
| Acetone and aqueous extracts |
| MIC ranged between 500 and 1,000 μg/ml |
|
| Y. enterocolitica | MIC ranged between 250 and 750 μg/ml | ||
| S. hominis | MIC ranged between 15 and 250 μg/ml | ||
| S. cohnii | MIC = 250 μg/ml, in both extracts | ||
| S. warneri | MIC ranged between 15 and 750 μg/ml | ||
|
| |||
| 85% MeOH |
| Φmm between 8.5 and 10.5 mm |
|
|
| |||
| Aqueous extract | Microsporum gypseum | IZ = 28.75 mm |
|
| Microsporum canis | IZ = 30.25 mm | ||
|
| IZ = 16 mm | ||
In vivo effects of S. jambos extracts.
| Extract | Doses | Route | Model | Activity | Country | Effects | Reference |
|---|---|---|---|---|---|---|---|
|
| |||||||
| Hydro-alcoholic | 100–300 mg/kg | Intraperitoneal injection | Male Sprague–Dawley rats | Anti-inflammatory | Venezuela | Analgesic effect on inflammatory cutaneous and deep muscle pain |
|
|
| |||||||
| Hydroethanolic | 400 mg/kg | Oral | Gastric injury induced by HCL/ethanol to rats | Anti-ulcerogenic | Brazil | Reduction of the subcronic ulcer |
|
| Ethanolic | 400 mg/kg | Oral | Rats, induced with acute inflammation | Anti-inflammatory | Bangladesh | Acute anti-inflammatory activity |
|
| Methanolic | 200 mg/kg | Oral | Rats, CCl4 acute induced hepatic injury | Hepatoprotective | Egypt | The extract decreased the levels of all measured liver makers, including ALT, AST, TB, TC, TG, and MDA, while increasing GSH and SOD. |
|
| 200 μg/ml | Juglone induced oxidative stress |
| Antioxidant | Decrease the intracellular ROS level in a dose dependent manner by 59.22%, the survival activity was also very low and dose dependent | |||
| Methanolic | 100–200 mg/kg | Oral | Paracetamol-induced hepatic damage in Wistar albino rats | Hepatoprotective | - | The extract cased a significant decrease in the serum hepatic enzyme levels, SGOT, SGPT, ALKP, and serum Bilirubin in dose-dependent manner |
|
| Ethanolic | 300 mg/kg | Intraperitoneal injection/oral | Rats, CCl4 induced hepatic injury | Hepatoprotective | Bangladesh | Gradual normalization of serum markers enzyme (SGPT, SGOT, ALP), total bilirubin, total protein, and liver weight |
|
| Methanolic | 250 mg/kg | NS | Rats, Ethylene glycol-induced urolithiasis model | Antiurolithiatic | India | reduced the phosphorus, calcium, urea, and creatinine levels in the serum |
|
| Ethanolic | 500 μg/ml | NS |
| Antioxidant | India | H2O2 scavenging potential |
|
| Decoction | 220 mg/kg | Oral | C57BL/J ob/ob Mice | Hypoglycemic | Puerto Rico | Better blood glucose modulation over time |
|
|
| |||||||
| Aqueous | 100–200 mg/kg | Oral | Streptozotocin–induced diabetes in rats | Antidiabetic | Egypt | Protective effects against STZ-induced diabetes |
|
| Improvement in glycemic parameters | |||||||
| Suppression of pancreatic oxidative stress, inflammation, apoptosis, and insulin signaling pathway in the liver | |||||||
|
| |||||||
| Pectic polysaccharides | 150, 250 mg/kg | Intraperitoneal injection | Mice bearing Ehrlich solid tumor | Antitumor | Brazil | Reduced tumor growth and improved the body weight of tumor bearing mice |
|
Ns: Not specified.
In vitro effects of S. jambos extracts.
| Extract | Activity | Used method | Country | Effects | Reference |
|---|---|---|---|---|---|
|
| |||||
|
| Antioxidant | DPPH and NO scavenging assay | South Africa | DPPH (IC50 = 14.10 µg/ml) NO scavenging assay (Low activity) |
|
| Anti-inflammatory | COX-2 | IC50 of 3.79 µg/ml | |||
| Cytotoxic | A375, A431, HeLa and HEK-293 cell lines | IC50 ranged between 56 and 198 µg/ml | |||
| Antiviral | Anti-herpes simplex virus type-1 assay | The extract exhibited potential anti-viral activity at 50.00 μg/ml | |||
| 100% viral inhibition when tested at the highest viral dose | |||||
|
| |||||
| Hydroethanol | Antioxidant | DPPH | Brazil | EC50 = 5.68 µg/ml |
|
| MDA | IC50 = 0.17 µg/ml | ||||
| Methanolic extract | Anti-inflammatory | Hyaluronidase inhibition assay | India | 60.80% inhibition at 1 µg/ml |
|
| Antioxidant | DPPH assay | IC50 = 41 ± 1.8 µg/ml | |||
| Nitric oxide assay | IC50 = 63 ± 1.6 µg/ml | ||||
| lipid peroxidation | IC50 = 48 ± 20 µg/ml | ||||
| Ethanolic extract | Antioxidant | ABTS | Bangladesh | IC50 = 57.80 µg/ml |
|
| Methanolic extract | Antioxidant | DPPH | Egypt | IC50 = 5.7 ± 0.45 µg/ml |
|
| FRAP | IC50 = 19.77 ± 0.79 mM | ||||
| Ethanolic extract | Anticancer | XXT | South Africa | IC50 < 60 µg/ml against the HeLa and A431 cell line |
|
| Antiviral | Cytopathic effect (CPE) inhibition assay | Potential antiviral activity with 100% viral inhibition for both (10 and 100 TCID50) viral doses against HSV-1 | |||
| Antioxidant | DPPH | IC50 = 1.17 ± 0.30 μg/ml | |||
| Methanolic, hexane and dichloromethane extract | Antiviral | Plaque Reduction Assay | Thailand | At 100 µg/ml, extracts of hexane and dichloromethane exhibited HSV-1/HSV-2 inhibitory activity greater than 50% inhibition |
|
| 70% aqueous acetone extract | Cytotoxicity | MTT assay | Taiwan | IC50 = 10.2 µg/ml strongest cytotoxic effect on human promyelocytic leukemia cells (HL-60) |
|
| Methanol extract | Cytotoxicity | SRB assay | Egypt | At 100 µg/ml, the extract exhibited an increase of MCF-7 cell proliferation |
|
| 85% MeOH | Antioxidant | Phosphomolybdenum assay | Egypt | 538.20 mg AAE/g extract |
|
| Deffated 85% MeOH | 619.51 mg AAE/g extract | ||||
| Petroleum ether | 147.96 mg AAE/g extract | ||||
| Dichloromethane | 222.76 mg AAE/g extract | ||||
| Ethyl acetate | 460.15 mg AAE/g extract | ||||
| n-Butanol | 643.90 mg AAE/g extract | ||||
| Aqueous | 315.44 mg AAE/g extract | ||||
| Ethanolic extract | Antioxidant | DPPH | Bangladesh | IC50 = 14.10 μg/ml |
|
| Methanolic and ZnO-NPs extract | Antiurolithiatic | Single diffusion gel growth technique | India | PI = 19.63–30.56% of inhibition at 2% of extract |
|
| PI = 16.28–24.68% of inhibition at 0.5% of extract for ZnO-NPs extract, PI = 25.60 at 0.5 and 35.27% at 5% | |||||
| Methanolic extract | Antioxidant | DPPH | Egypt | IC50 = 48.13 µg/ml |
|
| Ethanolic extract | Antioxidant | DPPH | India | IC50 = 38.73 µg/ml |
|
| Aqueous ethanolic extract | Antioxidant | DPPH | Egypt | EC50 = 13.52 ± 0.69 µg/ml |
|
| ORAC assay | EC50 = 34.35 ± 12.45 µg/ml | ||||
| Cytotoxicity | Neutral red uptake assay | HaCaT (IC50 = 106.74 ± 10.89 µg/ml) | |||
| Bladder carcinoma cells (IC50 = 55.24 ± 2.67 µg/ml) | |||||
|
| |||||
| Methanolic extract | Antioxidant | DPPH | United States | IC50 = 92.0 ± 8.24 µg/ml |
|
| Hydroalchohlic extract | Antioxidant | DPPH | Pahang | IC50 = 24.44 µg/ml |
|
| Ethanolic extract | Antioxidant | DPPH | Malaysia | Lowest activity, IC50 = 24.44 μg/ml | |
| Antidiabetic | α-Glucosidase inhibition assay | Low inhibition activity, IC50 = 0.67 ± 0.04 | |||
| n-Hexane, DCM and MeOH | Cytotoxicity | HeLa and Vero cell lines | Bangladesh | Not active |
|
|
| |||||
| Methanolic extract | Antioxidant | DPPH and ORAC | Brazil | 112.06 and 489.62 µmol/g Trolox equivalent, respectively |
|
| Ethanolic extract | Antioxidant | ABTS | China | IC50 = 45.79 ± 1.02 µg/ml |
|
| Hydroxyl radical activity | IC50 = 65.22 ± 0.93 µg/ml | ||||
| DPPH | IC50 = 95.21 ± 1.78 µg/ml | ||||
| Flowers | |||||
| 85% MeOH | Antioxidant | Phosphomolybdenum assay | Egypt | 560.97 mg AAE/g extract |
|
AAE: ascorbic acid equivalent; PI: percentage inhibition of the struvite crystals.